Maxime Ronot

@BavenoCoop The trial is negative though

CIRROXABAN Study is finally here! 🔬 First DB RCT evaluating rivaroxaban in cirrhosis 💡 Complication-free survival benefit in Child‑Pugh B7 (HR 0.26 [95 % CI 0.07–0.90]). ⚠️ Mild bleeding ↑, but no increase in severe events. 📄 journal-of-hepatology.eu/article/S0168-…

Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy | Targeted and Immune Therapy | JAMA Oncology | JAMA Network jamanetwork.com/journals/jamao…

🚨EASL CPG on the management of HCC in @JHepatology Major update! ✅ LI-RADS endorsed ✅ Refined treatment algo ✅ More evidence supporting locoregional treatments ✅ Up-to-date discussions 👉bit.ly/3VKZmcy

🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️ ✅Updated advice for managing patients with #HCC & comprehensive review of pertinent data Full text👉bit.ly/3VKZmcy #CPGs #LiverTwitter @EASLnews @EASLedu @AleksanderKrag

🔥off the press: Tumor burden with AFP improves survival prediction for TACE treated patients with HCC @JHEP_Reports doi.org/10.1016/j.jhep… 🔎 International observational study 👉Easy to use tool to predict outcome @myESMO @EASLedu @ILCAnews

❕Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study 🔓#OpenAccess at👉jhep-reports.eu/article/S2589-… #LiverTwitter #HCC @NaultJc

Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment - The Lancet Oncology thelancet.com/journals/lanon…

@JonathanStineMD @AASLDtweets Who takes the photos?

@AASLDtweets #TLM24 Day 4 workout on the books! In between you sessions, stop by the hotel gym for this circuit: 5 rounds (10-10-10 reps): ✅ DB cleans ✅ DB step ups with one legged standing press ✅ Rengade rows

🩺MRI-assessed intratumoral fat was generally nonprognostic; however, homogeneous intratumoral fat correlated with longer recurrence-free and overall survival in an Asian cohort of hepatocellular carcinoma patients. Findings from @maximeronot! pubs.rsna.org/doi/10.1148/ra…

Risk of HCC in Subcentimeter Liver Nodules Identified on Surveillance Ultrasound @AGA_CGH doi.org/10.1016/j.cgh.… 🔎 Systematic Review, 9 studies, 888 pts 👉risk of HCC: 21.3% 👉risk factors: older age, male sex, elevated AFP, low plts, CP B 🧐repeat ultrasound in 3-6 mo reasonable @myESMO @EASLnews @ILCAnews #livertwitter

Read 'open access' at bit.ly/3AdVol6 "Early-Life Infections, Antibiotics and Later Risk of Childhood and Early Adult-Onset Inflammatory Bowel Disease: Pooled Analysis of Two Scandinavian Birth Cohorts" by Mårild et al #GItwitter #IBD

💥EXPERT OPINION Integration of new technologies in the multidisciplinary approach to primary liver tumours ➡️The next-generation tumour board Full text here👉journal-of-hepatology.eu/article/S0168-… @Naultjc #LiverTwitter

🔥off the press Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC @JHEP_Reports 🔎🗺️RWD study ❓how to best select for TACE > AFP & Tumor burden 🧐helpful for the discussion in the tumor board 👇my author link: doi.org/10.1016/j.jhep… @myESMO @EASLedu @ILCAnews #livertwitter

The position paper from EASL about "management of rare primary liver cancers" was recently published in Journal Of Hepatology @EASLnews @JHepatology @campani_claudia @Zucmanrossi @ma5RN journal-of-hepatology.eu/article/S0168-…

Updated data for atezo + bev vs surveillance in resected or ablated high risk HCC #ESMO24 🔎IMbrave050 👉RFS 33.2 vs 36 mo, HR 0.9 👉OS: HR: 1.26 🧐Benefit not sustained! Disappointing.. 🧐Caveat of (too) early read outs… @myESMO #ESMOAmbassadors @ILCA @EASLedu

Preoperative mFOLFIRINOX with or without CRT in borderline resectable #PDAC #ESMO24 🔎Phs II trial PANDAS/PRODIGE 44 👉R0 resection 50 vs 55% 👉mOS 32.8 vs 30 mo 👉mOS 35.7 vs 47.9 mo (resected) 🧐no benefit in R0 rate or OS for CRT 🧐 mFOLFIRINOX with favorable OS

Congratulations to @F_matteini and team @marco_dioguardi @maximeronot @DrF_Vernuccio for the article "Discontinuous peripheral enhancement of focal liver lesions on CT and MRI: outside the box of typical cavernous hemangioma" published in @Abdominal_Rad 🔗doi.org/10.1007/s00261…

🚨 A new episode of the @radiology_rsna podcast is now available! 🚨 @LindaChuMD speaks with Dr. Lorenzo Garzelli and @maximeronot about Predictors of Intestinal Resection–Free Survival after Endovascular Revascularization #RadPodcasts bit.ly/4f9mrh2

@JHepatology And probably one of the best names for a protein

Van Gogh-like 2 is essential for the architectural patterning of the mammalian biliary tree Full text here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies Amazing collective work 💪 Everything there is to know, and more! + a new set of imaging criteria to play with ⬇️ thelancet.com/journals/langa… @ValdigGroup @RautouE